Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-07

Clinical Trial Update: Exhaled NO Testing in Filariasis

View source ↗

Summary

This completed trial evaluated exhaled nitric oxide testing as a non-invasive biomarker in individuals with lymphatic filariasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Filariasis | Status: COMPLETED